NCT05496426Phase 2Terminated early
A Study of KL130008 in Adults With Severe Alopecia Areata
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Trial Evaluating the Safety and Efficacy of KL130008 Capsule in Patients With Severe Alopecia Areata
In the register
The register attaches this trial to KL130008 (Kelun-Biotech), currently at “Discontinued” in the register. The programme's phase is checked by hand; the trial's is declared by its sponsor.
What the registry records
- Status
- Terminated early
- Declared phase
- Phase 2
- Sponsor
- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
- Participants (registry)
- 114
- Start
- November 2022
- Primary completion
- April 2024
- Study completion
- April 2024
- Last registry update
- May 2026
- Countries
- China
Conditions studied: Alopecia Areata
Interventions: KL130008/Placebo
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.